The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II study of S-1 plus ramucirumab as first-line treatment in elderly patients with advanced/recurrent gastric cancer (KSCC1701).
 
Hiroo Katsuya
No Relationships to Disclose
 
Koichi Suyama
No Relationships to Disclose
 
Kazuma Kobayashi
No Relationships to Disclose
 
Naoki Izawa
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Yoshikazu Uenosono
No Relationships to Disclose
 
Qingjiang Hu
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Hajime Otsu
No Relationships to Disclose
 
Hiroyuki Orita
No Relationships to Disclose
 
Hirofumi Kawanaka
No Relationships to Disclose
 
Kazunori Shibao
No Relationships to Disclose
 
Satoshi Koga
No Relationships to Disclose
 
Mototsugu Shimokawa
Consulting or Advisory Role - Sysmex
 
Akitaka Makiyama
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Lilly Japan
 
Hiroshi Saeki
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Hideo Baba
Honoraria - Taiho Pharmaceutical
Research Funding - Asahi Kasei; Chugai Pharma (Inst); Johnson & Johnson K.K.; Lilly Japan; MSD K.K (Inst); Shin Nippon Biomedical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Masaki Mori
No Relationships to Disclose